LLY vs STE
By Alex · Tickerpine
Eli Lilly and Company vs STERIS plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | STE |
|---|---|---|
| Price | $1,220.28 | $236.60 |
| Market cap | $1.09T | $23.07B |
| P/E ratio | 41.0 | 29.1 |
| ROE | 102.29% | 11.39% |
| Profit margin | 33.53% | 13.33% |
| Revenue growth | 47.70% | 7.30% |
| Dividend yield | 0.57% | 1.08% |
| Beta | 0.51 | 0.91 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs STE in plain English
- LLY is the bigger company — about 47.2× the market cap of STE.
- STE is cheaper on earnings (P/E 29.1 vs 41.0).
- LLY earns a higher return on equity (102% vs 11%).
- LLY is growing revenue faster (48% vs 7%).
- STE has the higher dividend yield (1.08% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
STE return calculator
See what $1,000 in STERIS plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.